OTTAWA, Ontario--(BUSINESS WIRE)-- BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active ...
ArriVent BioPharma (AVBP), which is developing a drug to treat certain types of lung cancer, has filed for a proposed $100M initial public offering. The biotech company didn’t specify any terms in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback